A Phase I Study to Examine the Effects of Low and High-fat Meals on Orally Administered XZP-3287 in Healthy Adult Subjects
Latest Information Update: 05 Jun 2023
At a glance
- Drugs Birociclib (Primary)
- Indications Breast cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors XuanZhu Pharma
- 20 Jul 2021 Status changed from not yet recruiting to recruiting.
- 09 Jul 2021 New trial record